What's New
-
2023-11-15
(15 November 2023, Hong Kong) HKSH Medical Group (HKSH), LKS Faculty of Medicine of the University of Hong Kong (HKUMed), and the Hong Kong Hereditary Breast Cancer Family Registry (Registry) today announced significant findings from their collaborative research studies on the germline mutation landscape of nearly 4,900 individuals with hereditary breast and/or ovarian cancers... -
2023-10-04
(4 October 2023, Hong Kong) HKSH Medical Group (HKSH) today announced that it has received a generous donation of HK$ 1 million from Mr. Li Ka Shing to sponsor two paediatric cancer patients referred by the Hong Kong Children’s Hospital of the Hospital Authority to receive proton therapy at HKSH.
The two adolescent boys (aged 15 and 13) were referred with malignant... -
2023-09-11
-
2023-09-08
(8 September 2023, Hong Kong) The Li Shu Fan Medical Foundation (the Foundation) and the Royal College of Surgeons of Edinburgh (RCSEd) today made an announcement regarding a donation of £1 million (equivalent to approximately HK$10 million) from the Foundation to RCSEd. The donation will be allocated towards the establishment of the RCSEd Dr Li Shu Fan International... -
2023-06-12
(Hong Kong, June 12, 2023) HKSH Medical Group (HKSH) and UCLA Health have signed a Development Agreement to strengthen their partnership in knowledge transfer in cancer management. The two institutions share common academic and clinical interests and are committed to sharing expertise and best practices in cancer management.
Please click here for more information.
